ClinicalTrials.gov
public full text
Public Domain
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
Null hypothesis of the trial is that there is no difference between solifenacin and oxybutynin with respect to efficacy, side effects, patient satisfaction and quality of life measures in patients with overactive bladder.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment#889703
- Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder#825707
- Treatment of Overactive Bladder With Anticholinergic Agents#992542
- A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment#853274
- Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania#906319
Record · ID 993392
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive